Recognition and treatment of response fluctuations in Parkinson's disease: Review article

Amino Acids

Volumn 23, Issue 1-3, 2002, Pages 141-145

  Verhagen Metman, L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dyskinesias; Levodopa treatment; Motor response complications

Indexed keywords

DOPAMINE; GLUTAMATE RECEPTOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANAMNESIS; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG RESPONSE; DYSKINESIA; HUMAN; INVOLUNTARY MOVEMENT; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE CELL; PARKINSON DISEASE; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; MOTOR ACTIVITY; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 0036389377     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-001-0119-1     Document Type: Conference Paper

References (20)

1. Blanchet PJ, Gregoire L, Tardif F, Bedard PJ (1996) Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients. Can J Neurol Sci 23: 189-193
2. Chase TN, Engber TM, Mouradian MM (1996) Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease. Adv Neurol 69: 497-501
3. Djadetti R, Melamed E (1998) Management of response fluctuations. Practical guidelines. Neurology 51 [Suppl 2]: S36-S40
4. Hardie RJ, Lees AJ, Stern GM (1984) On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. Brain 107: 487-506
5. Hillen M, Sage JI (1996) Nonmotor fluctuations in patients with Parkinson's disease. Neurology 47: 1180-1183
6. Kidron D, Melamed E (1987) Forms of dystonia in patients with Parkinson's disease. Neurology 37: 1009-1011
7. LeWitt PA, Burns RS, Newmann RP (1986) Dystonia in untreated parkinsonism. Clin Neuropharmacol 9: 293-297
8. Marsden CD, Parkes JD, Quinn N (1981) Fluctuations of disability in Parkinson's disease - clinical aspects. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 96-122
9. Mizuno Y, Kondo T, Mori H (1994) Various aspects of motor fluctuations and their management in Parkinson's disease. Neurology 44 [Suppl 6]: S29-S34
10. Pincus JH, Barry K (1988) Protein redistribution diet restores motor function in patients with dopa-resistant "off" periods. Neurology 38: 481-483
11. Poewe WH (1994) Clinical aspects of motor fluctuations in Parkinson's disease. Neurology 44 [Suppl 6]: S6-S9
12. Poewe WH, Lees AJ, Stern GM (1988) Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 23: 73-78
13. Purves Stewart J (1898) Paralysis agitans; with an account of a new symptom. Lancet ii: 1258-1260
14. Quinn NP (1998) Classification of fluctuations in patients with Parkinson's disease. Neurology 51 [Suppl 2]: S25-S29
15. Riley DE, Lang AE (1993) The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology 43: 1459-1464
16. Souques MA (1921) Rapport sur les syndromes parkinsoniens. Rev Neurol 37: 534-573
17. Tolosa ES, Valldeoriola R, Marti MJ (1994) New and emerging strategies for improving levodopa treatment. Neurology 44 [Suppl 6]: S35-S44
18. Verhagen Metman L, Del Dotto P, van den Munckhof P, Fang J, Mouradian MM, Chase TN (1998) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Neurology 50: 1323-1326
19. Verhagen Metman L, Locatelli ER, Bravi D, Mouradian MM, Chase TN (1997) Apomorphine responses in Parkinsons's disease and the pathogenesis of motor complications. Neurology 48: 369-372
20. Wade DN, Mearrick PT, Morris JL (1973) Active transport of L-dopa in the intestine. Nature 242: 463-465